tiprankstipranks
Diamedica Therapeutics (DMAC)
:DMAC
US Market

Diamedica Therapeutics (DMAC) Technical Analysis

Compare
485 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Diamedica Therapeutics’s (DMAC) Moving Averages Convergence Divergence (MACD) indicator is 0.23, suggesting Diamedica Therapeutics is a Sell.
Diamedica Therapeutics’s (DMAC) 20-Day exponential moving average is 6.19, while Diamedica Therapeutics’s (DMAC) share price is $6.51, making it a Buy.
Diamedica Therapeutics’s (DMAC) 50-Day exponential moving average is 5.77, while Diamedica Therapeutics’s (DMAC) share price is $6.51, making it a Buy.

Diamedica Therapeutics (DMAC) Pivot Points

Feb 22, 2025, 03:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.27
6.42
6.51
6.66
6.75
6.90
6.99
Fibonacci
6.42
6.51
6.56
6.66
6.75
6.80
6.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Diamedica Therapeutics (DMAC) Moving Averages

Feb 22, 2025, 03:26 PM
Period
Simple
Exponential
MA5
6.44Buy
6.47Buy
MA10
6.37Buy
6.36Buy
MA20
6.18Buy
6.19Buy
MA50
5.74Buy
5.77Buy
MA100
5.12Buy
5.23Buy
MA200
4.23Buy
4.39Buy
Diamedica Therapeutics’s (DMAC) 10-Day exponential moving average is 6.36, while Diamedica Therapeutics’s (DMAC) share price is $6.51, making it a Buy.
Diamedica Therapeutics’s (DMAC) 100-Day exponential moving average is 5.23, while Diamedica Therapeutics’s (DMAC) share price is $6.51, making it a Buy.
Diamedica Therapeutics’s (DMAC) stock price is $6.51 and Diamedica Therapeutics’s (DMAC) 50-day simple moving average is 5.74, creating a Buy signal.
Diamedica Therapeutics’s (DMAC) stock price is $6.51 and Diamedica Therapeutics’s (DMAC) 100-day simple moving average is 5.12, creating a Buy signal.
Diamedica Therapeutics’s (DMAC) stock price is $6.51 and Diamedica Therapeutics’s (DMAC) 200-day simple moving average is 4.23, creating a Buy signal.

Diamedica Therapeutics (DMAC) Technical Indicators

Feb 22, 2025, 03:26 PM
Name
Value
Implied Action
RSI (14)
62.22
Neutral
STOCH (9,6)
78.65
Neutral
STOCHRSI (14)
81.21
Sell
MACD (12,26)
0.23
Sell
ADX (14)
21.11
Neutral
Williams %R
-25.50
Buy
CCI (14)
136.31
Sell
ATR (14)
0.35
-
Ultimate Oscillator
61.72
Neutral
ROC
13.02
Buy
Diamedica Therapeutics’s (DMAC) Relative Strength Index (RSI) is 62.22, creating a Neutral signal.
Diamedica Therapeutics’s (DMAC) Trend Strength Indicator (ADX) is 21.11, creating a Neutral signal.
Diamedica Therapeutics’s (DMAC) Commodity Channel Index (CCI) is 136.31, creating a Sell signal.
Diamedica Therapeutics’s (DMAC) Price Rate of Change (ROC) is 13.02, creating a Buy signal.

FAQ

Is DMAC a Buy, Hold, or Sell?
Based on DMAC’s technical indicators, DMAC is a Strong Buy.
    What is DMAC’s RSI (14)?
    DMAC’s RSI (14) is 62.22, which suggests DMAC is a Neutral.
      What is DMAC’s MACD?
      DMAC’s MACD is 0.23, which suggests DMAC is a Sell.
        What is DMAC’s 5-day moving average?
        DMAC’s 5-day moving average is 6.44, which suggests DMAC is a Buy.
          What is DMAC’s 20-day moving average?
          DMAC 20-day moving average is 6.18, which suggests DMAC is a Buy.
            What is DMAC’s 50-day moving average?
            DMAC’s 50-day moving average is 5.74, which suggests DMAC is a Buy.
              What is DMAC’s 200-day moving average?
              DMAC’s 200-day moving average is 4.23, which suggests DMAC is a Buy.
                What is DMAC’s Williams % R (14)?
                DMAC’s Williams % R (14) is -25.50, which suggests DMAC is a Buy.
                  What is DMAC’s CCI (14)?
                  DMAC’s CCI (14) is 136.31, which suggests DMAC is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis